{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:40:36Z","timestamp":1788972036257,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1445,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.vaccine.2009.06.042","type":"journal-article","created":{"date-parts":[[2009,6,28]],"date-time":"2009-06-28T04:12:23Z","timestamp":1246162343000},"page":"4923-4929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi"],"prefix":"10.1016","volume":"27","author":[{"given":"Claire E.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathiba","family":"Kurupati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siouxsie","family":"Wiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiranee","family":"Sriskandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2009.06.042_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2009.06.042_bib2","doi-asserted-by":"crossref","first-page":"s533","DOI":"10.2741\/1067","article-title":"Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease","volume":"8","author":"Cunningham","year":"2003","journal-title":"Front Biosci"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.042_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1084\/jem.161.1.113","article-title":"Multiple, heart-cross-reactive epitopes of streptococcal M proteins","volume":"161","author":"Dale","year":"1985","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.06.042_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4684-6000-1_17","article-title":"Protection against streptococcal pharyngeal colonization with vaccines composed of M protein conserved regions","volume":"303","author":"Fischetti","year":"1991","journal-title":"Adv Exp Med Biol"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2009.06.042_bib5","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/S0264-410X(02)00205-0","article-title":"Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope","volume":"20","author":"Olive","year":"2002","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2009.06.042_bib6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers","volume":"41","author":"McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2009.06.042_bib7","first-page":"833","article-title":"Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes","volume":"12","author":"Dale","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.042_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.292.6.709","article-title":"Safety and immunogenicity of a recombinant multivalent group A streptococcal vaccine in healthy adults: phase 1 trial","volume":"292","author":"Kotloff","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.042_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/prca.200780048","article-title":"Human pathogenic streptococcal proteomics and vaccine development","volume":"2","author":"Cole","year":"2008","journal-title":"Proteomics Clin Appl"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.042_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nbt1179","article-title":"Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome","volume":"24","author":"Rodriguez-Ortega","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.042_bib11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/432485","article-title":"Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes","volume":"192","author":"Edwards","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.042_bib12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.tvjl.2006.05.011","article-title":"Getting a grip on Strangles: recent progress towards improved diagnostics and vaccines","volume":"173","author":"Waller","year":"2007","journal-title":"Vet J"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.042_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.chom.2008.07.002","article-title":"The IL-8 protease SpyCEP\/ScpC of group A Streptococcus promotes resistance to neutrophil killing","volume":"4","author":"Zinkernagel","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.vaccine.2009.06.042_bib14","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1128\/IAI.69.11.7029-7038.2001","article-title":"Generation and surface localization of intact M protein in Streptococcus pyogenes are dependent on sagA","volume":"69","author":"Biswas","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.042_bib15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1128\/IAI.01354-07","article-title":"A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response","volume":"76","author":"Sumby","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.06.042_bib16","doi-asserted-by":"crossref","unstructured":"Turner CE, Kurupati P, Jones MD, Edwards RJ, Sriskandan S. Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection. J Infect Dis 2009; in press.","DOI":"10.1086\/603541"},{"issue":"19","key":"10.1016\/j.vaccine.2009.06.042_bib17","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1038\/sj.emboj.7601327","article-title":"A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues","volume":"25","author":"Hidalgo-Grass","year":"2006","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/j.vaccine.2009.06.042_bib18","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1128\/IAI.00128-08","article-title":"The ScpC protease of Streptococcus pyogenes affects the outcome of sepsis in a murine model","volume":"76","author":"Sjolinder","year":"2008","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.042_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1128\/CMR.2.3.285","article-title":"M protein: molecular design and biological behavior","volume":"2","author":"Fischetti","year":"1989","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.042_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1051\/vetres:2004025","article-title":"The pathogenic equine streptococci","volume":"35","author":"Timoney","year":"2004","journal-title":"Vet Res"},{"issue":"8","key":"10.1016\/j.vaccine.2009.06.042_bib21","doi-asserted-by":"crossref","first-page":"e3026","DOI":"10.1371\/journal.pone.0003026","article-title":"Genome sequence of a Lancefield group C Streptococcus zooepidemicus strain causing epidemic nephritis: new information about an old disease","volume":"3","author":"Beres","year":"2008","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09008895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09008895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:16:07Z","timestamp":1759400167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09008895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":21,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0264410X09008895"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}